Dr Svetla Gadzhanova

Dr Svetla Gadzhanova

School of Pharmacy and Biomedical Science

College of Health

I am a Research Fellow within the quality use of medicines and pharmacy research centre. I have been working on drug utlisation post marketing reviews of Pharmaceutical Benefits Scheme (PBS) medicines for the Australian Government Department of Heath and Aged care as well as on analysis of PBS data for the national reports on antimicrobal use and resistence in Australia (AURA) for the Australian Commission on Safety and Quality in Heath Care.

Pharmacoepidemiology and quality use of medicines,Data mining (special focus on temporal data abstraction) of data from elecronic health records.,Evaluation of change management behaviour in Primary Health Care

Date Institution name Country Title
University of South Australia Australia PhD

Year Citation
2025 Chan, A. Y. L., Bahmanyar, S., Beyene, K., Bushnell, G., Gadzhanova, S., & Roughead, E. E. (2025). International trends in opioid prescribing by age and sex from 2001 to 2019: an observational study using population-based databases from 18 countries and one special administrative region. Cns Drugs, 39(11), 1173-1185.
DOI Scopus1
2024 Gadzhanova, S., & Roughead, E. (2024). Use of Analgesic and Anti-Inflammatory Medicines before and after Initiation of Biological Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2024(8040681), 7 pages.
DOI Scopus3 WoS3
2024 Le, T. N., Afshar Ali, M., Gadzhanova, S., Lim, R., Bala, I., Bogale, K. N., & Gillam, M. (2024). Hernia repair prevalence by age and gender among the Australian adult population from 2017 to 2021. Critical Public Health, 34(1), 1-11.
DOI Scopus2
2021 Park, S. H., Jeon, H. L., Kim, S. C., Hillen, J., Gadzhanova, S., Shin, J. Y., & Pratt, N. (2021). Utilization of targeted disease-modifying anti-rheumatic drugs (DMARDs) for managing rheumatoid arthritis in the last decade: A two-country comparison. International Journal of Clinical Pharmacology and Therapeutics, 59(10), 639-644.
DOI Scopus2 WoS2 Europe PMC2
2021 De Vries, C., Gadzhanova, S., Sykes, M. J., Ward, M., & Roughead, E. (2021). A systematic review and meta-analysis considering the risk for congenital heart defects of antidepressant classes and individual antidepressants. Drug Safety, 44(3), 291-312.
DOI Scopus42 WoS34 Europe PMC23
2020 Gadzhanova, S., Roughead, E., Lowy, H., & O'Connor, D. (2020). Reducing adverse medication events in mental health: Australian National Survey. International journal of evidence-based healthcare, 18(1), 108-115.
DOI Scopus3 WoS3 Europe PMC2
2020 Gadzhanova, S., Gillam, M., & Roughead, E. (2020). Risk of falls and injuries requiring hospitalisation after first-eye cataract surgery in elderly Australians. Acta Ophthalmologica, 98(4), e495-e498.
DOI Scopus5 WoS4 Europe PMC4
2019 Caughey, G. E., Gadzhanova, S., Shakib, S., & Roughead, E. E. (2019). Concomitant prescribing of opioids and benzodiazepines in Australia, 2012–2017. Medical Journal of Australia, 210(1), 39-40.
DOI Scopus9 WoS9 Europe PMC7
2019 Ellett, L. M. K., Moffat, A. K., Gadzhanova, S., Pratt, N. L., Apajee, J., Woodward, M., & Roughead, E. E. (2019). Reduction in Use of Risperidone for Dementia in Australia Following Changed Guidelines. PHARMACY, 7(3), 11 pages.
DOI WoS6 Europe PMC7
2019 Kalisch Ellett, L. M., Moffat, A. K., Gadzhanova, S., Pratt, N. L., Apajee, J., Woodward, M., & Roughead, E. E. (Eds.) (2019). Reduction in use of risperidone for dementia in Australia following changed guidelines. Pharmacy, 7(3), 1-11.
2018 Gadzhanova, S., Roughead, E., & Bartlett, L. (2018). Utilisation of medicines for treatment of multiple myeloma in Australia. Pharmacoepidemiology and drug safety, 27(S2), 432.
2018 Gadzhanova, S., & Roughead, E. (2018). Comparison of General Practice and Pharmaceutical Dispensing Data for Pharmacoepidemiological Research: Assessing the Risk of Urinary-Tract Infections with Sodium Glucose Cotransporter 2 Inhibitors for Diabetes. ADVANCES IN PUBLIC HEALTH, 2018, 6 pages.
DOI
2018 Gadzhanova, S., Roughead, E. E., & Pont, L. G. (2018). Antidepressant switching patterns in the elderly. International psychogeriatrics, 30(9), 1365-1374.
DOI Scopus10 WoS8 Europe PMC6
2017 Gadzhanova, S., Pratt, N., & Roughead, E. (2017). Use of SGLT2 inhibitors for diabetes and risk of infection: Analysis using general practice records from the NPS MedicineWise MedicineInsight program. Diabetes Research and Clinical Practice, 130, 180-185.
DOI Scopus50 WoS48 Europe PMC45
2017 Pratt, N. L., Kalisch Ellett, L. M., Sluggett, J. K., Gadzhanova, S. V., Ramsay, E. N., Kerr, M., . . . Roughead, E. E. (2017). Use of proton pump inhibitors among older Australians: National quality improvement programmes have led to sustained practice change. International Journal for Quality in Health Care, 29(1), 75-82.
DOI Scopus27 WoS21 Europe PMC22
2016 Gadzhanova, S., & Roughead, E. (2016). Prescribed antibiotic use in Australian children aged 0-12 years. Australian family physician, 45(3), 134-138.
Scopus12 WoS9 Europe PMC10
2016 Gadzhanova, S., Roughead, E. E., & Bartlett, L. E. (2016). Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia. European Journal of Clinical Pharmacology, 72(6), 1-7.
DOI Scopus7 WoS7 Europe PMC7
2016 Shin, H. Y., Gadzhanova, S., Roughead, E. E., Ward, M. B., & Pont, L. G. (2016). The use of antipsychotics among people treated with medications for dementia in residential aged care facilities. International Psychogeriatrics, 28(6), 977-982.
DOI Scopus12 WoS13 Europe PMC12
2015 Gadzhanova, S., Roughead, E. E., & Pont, L. G. (2015). Safety of opioid patch initiation in Australian residential aged care. Medical Journal of Australia, 203(7), 298.e1-298.e6.
DOI Scopus14 WoS12 Europe PMC11
2015 Gadzhanova, S., & Roughead, E. (2015). Use of prescription medicines in Australian women of child-bearing age. BMC Pharmacology and Toxicology, 16(1), 1-12.
DOI Scopus7 WoS6 Europe PMC6
2015 Gadzhanova, S., Roughead, E., & Robinson, M. (2015). Use of medicines with anticholinergic and sedative effect before and after initiation of anti-dementia medications. Drugs, 2(1), 53-60.
DOI Scopus15 Europe PMC13
2015 Gadzhanova, S., & Roughead, E. (2015). Survival after initiation of androgen deprivation therapy for prostate cancer of Australian men. Cancer Epidemiology, 39(6), 854-859.
DOI Scopus2 WoS1
2014 Gadzhanova, S., Roughead, E., & Ilomaki, J. (2014). Use of statins in an Australian elderly population. International journal of clinical cardiology, 1(3, article no. 016), 1-4.
2014 Gadzhanova, S., & Roughead, E. (2014). Co-prescribing of warfarin with statins and Proton Pump Inhibitors in elderly Australians. Advances in pharmacoepidemiology & drug safety, 3(3), 1-4.
DOI
2013 Gadzhanova, S., Bell, J. S., & Roughead, E. E. (2013). What analgesics do older people use prior to initiating oxycodone for non-cancer pain?: a retrospective database study. Drugs & aging, 30(11), 921-926.
DOI Scopus16 WoS16 Europe PMC15
2013 Gadzhanova, S., Ilomäki, J., & Roughead, E. E. (2013). Antihypertensive use before and after initiation of fixed-dose combination products in Australia: a retrospective study. International journal of clinical pharmacy, 35(4), 613-620.
DOI Scopus7 WoS7 Europe PMC5
2013 Gadzhanova, S. V., Roughead, E. E., & Bartlett, M. J. (2013). Improving cardiovascular disease management in Australia : NPS MedicineWise. Medical journal of Australia, 199(3), 192-195.
DOI Scopus11 WoS11 Europe PMC9
2012 Gadzhanova, S., Ilomaki, J., & Roughead, E. E. (2012). COX-2 inhibitor and non-selective NSAID use in those at increased risk of NSAID-related adverse events: a retrospective database study. Drugs & aging, 30(1), 23-30.
DOI Scopus9 WoS8 Europe PMC6
2011 Gadzhanova, S., Roughead, E. E., Loukas, K., & Vajda, J. (2011). Improvement in metformin and insulin utilisation in the Australian veteran population associated with quality use of medicines intervention programs. Pharmacoepidemiology and drug safety, 20(4), 359-365.
DOI Scopus4 WoS4 Europe PMC3
2011 Gadzhanova, S. V., Roughead, E. E., & Mackson, J. M. (2011). Initiation and duration of proton pump inhibitors in the Australian veteran population. Internal medicine journal, 42(5), e68-e73.
DOI Scopus14 WoS11 Europe PMC13
2011 Gadzhanova, S. V., Gillies, M., Roughead, E. E., & Zuo, Y. (2011). Fixed dose combination diabetes medicines: usage in the Australian veteran population. Australian Family Physician, 40(10), 811-815.
Scopus5 WoS4 Europe PMC4
2010 Gadzhanova, S. V., Roughead, E. E., & Mackson, J. (2010). Anticholinesterase duration in the Australian veteran population. Australian and New Zealand journal of psychiatry, 44(5), 469-474.
DOI Scopus11 WoS11 Europe PMC10
2007 Gadzhanova, S., Iankov, I., Warren, J., Stanek, J., Misan, G., Baig, M., & Ponte, L. (2007). Developing high-specificity anti-hypertensive alerts by therapeutic state analysis of electronic prescribing records. Journal of the American Medical Informatics Association, 14(1), 100-109.
DOI Scopus6 WoS4 Europe PMC2
2007 Gadzhanova, S., & Reed, R. (2007). Medical services provided by general practitioners in residential aged-care facilities in Australia. Medical Journal of Australia, 187(2), 92-94.
DOI Scopus33 WoS33 Europe PMC21
2006 Warren, J. R., Stanek, J., Gadzhanov, S. V., Iankov, I. I., & Misan, G. M. (2006). Inferring 'Therapeutic States' of Patients from Community Electronic Prescribing Data. Electronic Journal of Health Informatics.
2002 Gadzhanov, S. V., Stanek, J., & Warren, J. R. (2002). Clinical user interfaces that learn from experience. Informatics in Primary Care: Best Practice in Healthcare Informatics Delivery.

Year Citation
2025 Gadzhanova, S. (2025). Incident cancer and its effect on health-related quality of life trajectories among Australian older adults. In AUSTRALIAN JOURNAL OF PRIMARY HEALTH Vol. 31 (pp. 51 pages). CSIRO PUBLISHING.
2012 Gadzhanova, S., Bell, S., & Roughead, E. (2012). Oxycodone Use in Australian Veterans at Risk of Respiratory Depression. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 21 (pp. 77-78). WILEY PERIODICALS, INC.
2012 Ilomaki, J., Gadzhanova, S., & Roughead, E. E. (2012). COX-2 and Non-Selective NSAID Use in Those at Increased Risk of NSAID-Related Adverse Events. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 21 (pp. 70). WILEY PERIODICALS, INC.
2005 Stanek, J., Iankov, I. I., Gadzhanov, S. V., Warren, J. R., & Misan, G. M. H. (2005). Guideline-based general practice data mining. In HIC 2005 Proceedings: The Thirteenth Annual Health Informatics Conference. Australia: Health Informatics Society of Australia.
2005 Warren, J., Gadzhanova, S., Stanek, J., & Iankov, I. I. (2005). Understanding caseload and practice through analysis of therapeutic state transitions. In AMIA 2005 Vol. 2005 (pp. 784-788). USA: American Medical Informatics Association.
Scopus4 Europe PMC1
2003 Warren, J. R., Stanek, J., Gadzhanova, S. V., & Misan, G. M. H. (2003). General practice data mining - making the best of practical and fundamental limitations. In E. Simpson (Ed.), Proceedings of the Eleventh National Health Informatics Conference and Twelfth National RACGP Computer Conference. Australia: Health Informatics Society of Australia Ltd and Royal Australian College of General Practitioners.

Year Citation
2017 Caughey, G. E., Gadzhanova, S., Shakib, S., & Roughead, E. E. (2017). Trends in Concomitant Prescribing of Opioids and Benzodiazepines in Australia 2010-2015; a Cause for Concern?. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY.

Year Citation
2020 De Vries, C., Gadzhanova, S., Sykes, M. J., Ward, M., & Roughead, E. (2020). A systematic review and meta-analysis considering the SSRI, SNRI and TCA classes of antidepressants and the risk for congenital heart defects.
DOI

  • Analysis of PBS data for National Report on Antimicrobial Use and Resistance 2024, Australian Commission on Safety and Quality in Health Care, 17/04/2025 - 31/08/2025

  • Quality Use of Medicines Literature Review PH23/5815, Cwth Dept of Health Aged Care, 22/06/2023 - 17/05/2024

  • Utilisation review of prostacyclin analogue medicines for the treatment of pulmonary arterial hypertension (PAH), Cwth Dept of Health Aged Care, 26/03/2021 - 15/10/2021

  • PBS/RPBS Data Analysis and Report for the Antimicrobial use and resistance in Australia (AURA) Program, Australian Commission on Safety and Quality in Health Care, 21/01/2021 - 30/06/2021

Connect With Me

External Profiles

Other Links